Gaize, Inc.
Missoula, Montana, 59804, United States
NCT Number: NCT07126938
This study evaluates the effectiveness of the Gaize virtual reality headset as a non-invasive tool for detecting alcohol-related impairment through ophthalmic and neurological indicators. A total of 80 participants, evenly divided into an experimental (alcohol-consuming) and control (non-alcohol consuming) group, underwent baseline and post-consumption ocular assessments using the device. These assessments included: Lack of Smooth Pursuit, Horizontal Gaze Nystagmus at Maximum Deviation, Horizontal Gaze Nystagmus with Onset Prior to 45-Degrees, Vertical Gaze Nystagmus, Lack of Convergence, and Pupillary Rebound Dilation. The Gaize headset measured gaze vector and pupil size at 90 hertz per eye.
Looking for future studies?
Notify Me21 year–45 year
All sexes
Observational
Missoula, Montana, 59804, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants in the experimental group consumed self-selected amounts of alcohol, monitored by study staff to ensure safety and compliance with protocol guidelines. Participants then filled out the remainder of the general health questionnaire, including how many drinks they consumed, and whether or not they feel too impaired to drive a vehicle or go to work.
Other names: Alcohol, Ethanol
Time frame: 1 hour after alcohol consumption
Number of participants and measurement of Lack of Smooth Pursuit, Horizontal Gaze Nystagmus at Maximum Deviation, Horizontal Gaze Nystagmus with Onset Prior to 45-Degrees, and Vertical Gaze Nystagmus were evaluated before and after alcohol consumption.
Time frame: 1 hour after Alcohol consumption
Number of participants and measurement of Lack of Convergence, and Pupillary Rebound Dilation were evaluated before and after alcohol consumption.
Gaize
Industry
An Observational Study to Facilitate the Development of an Alcohol Impairment Detection Device in Healthy Adult Alcohol Users
Acronym: AAI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03521115
Alcohol Abstinence, Alcohol Drinking
Berkeley, California, United States
View Trial DetailsNCT03335735
Alcohol Drinking, Alcohol Impairment
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT04856566
Alcohol Impairment, Chemically-Induced Disorders
Hartford, Connecticut, United States
View Trial DetailsNCT01590277
Active Ethanol and Active Iomazenil, Active Ethanol and Placebo Iomazenil
West Haven, Connecticut, United States
View Trial Details